Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparison of venlafaxine and midodrine in preventing hypotension due to hemodialysis
IRCT20151205025372N2Phase 3Completed
- Sponsor
- Urmia University of Medical Sciences
- Start
- Feb 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of venlafaxine and midodrine in intradialytic hypotension (IDH) (2 arms), sponsored by Urmia University of Medical Sciences. Primary endpoint: Incidence of intradialytic hypotension. Started Feb 2019; status: completed.
02
Drugs
venlafaxinemidodrine
03
Conditions
intradialytic hypotension (IDH)
Beyond the preview
Go deeper on IRCT20151205025372N2.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20151205025372N2.